Partex's platform will provide comprehensive analyses, including target identification, indication expansion, and molecular profiling, ultimately accelerating the process of bringing innovative ...

pharmaceuticals are unlikely to de-globalise or shift heavily toward regional production. Instead, companies are embracing growth strategies, such as mergers, acquisitions, and asset swaps.

NB Renaissance sees pharmaceutical assets as core to its investment strategy. In 2022, it partnered with Ardian to acquire a majority stake in Italy’s Neopharmed Gentili, which specializes in ...

Atria Investments Inc bought a new position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the 4th quarter, HoldingsChannel.com reports. The fund bought 7,978 shares of the specialty ...

Atria Investments Inc lifted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 19.5% during the fourth ...

Knight Therapeutics has agreed to acquire generics and specialty branded pharmaceutical company Paladin Pharma for 120 million Canadian dollars ($83.1 million).

Apellis Pharmaceuticals Inc (NASDAQ:APLS) reported a fourth-quarter earnings loss of 29 cents per share, beating the ...

Britain's Alliance Pharma said on Monday it has agreed to a sweetened final cash proposal from asset management firm DBAY Advisors, valuing the healthcare group at about 362 million pounds ($467.5 ...